SEC Company Response from Pulmonx (LUNG) — Sep 28, 2020
Pulmonx Corp
Date: Sept. 28, 2020 · CIK: 0001127537 · Accession: 0001628280-20-013936
AI Filing Summary & Sentiment
File numbers found in text: 333-248635
Show Raw Text
CORRESP 1 filename1.htm Document Pulmonx Corporation 700 Chesapeake Drive Redwood City, CA 94063 September 28, 2020 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington D.C., 20549 Attn: Al Pavot Ada Sarmento Joseph McCann RE: Pulmonx Corporation Registration Statement on Form S-1 File No. 333-248635 Ladies and Gentlemen: Pulmonx Corporation (the “Registrant”) hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-1 to become effective on Wednesday, September 30, 2020, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes each of Seth J. Gottlieb and Sepideh Mousakhani of Cooley LLP, counsel to the Registrant, to make such request on its behalf. Once the Registration Statement has been declared effective, please orally confirm that event with Seth J. Gottlieb of Cooley LLP, counsel to the Registrant, at (650) 843-5864, or in his absence, Sepideh Mousakhani at (650) 849-7009. [Signature Page Follows] Very truly yours, PULMONX CORPORATION By: /s/ Glendon E. French Name: Glendon E. French Title: Chief Executive Officer cc: Glendon E. French, Pulmonx Corporation Mark B. Weeks, Cooley LLP Seth J. Gottlieb, Cooley LLP Sepideh Mousakhani, Cooley LLP Ilir Mujalovic, Shearman & Sterling LLP [COMPANY SIGNATURE PAGE TO ACCELERATION REQUEST]